Traditional reactive carbonyl scavengers do not prevent the carbonylation of brain proteins induced by acute glutathione depletion

References

• Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 1997;10:485–494.
   PubMed Web of Science ®Google Scholar
• Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002;32:790–796.
   PubMed Web of Science ®Google Scholar
• Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001;103:373–383.
   PubMed Web of Science ®Google Scholar
• Floor E, Wetzel MG. Increased protein oxidation in human sustantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem 1998;70:268–275.
   PubMed Web of Science ®Google Scholar
• Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH, Beal MF. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997;69:2064–2074.
   PubMed Web of Science ®Google Scholar
• Bizzozero OA, Dejesus G, Callahan K, Pastuszyn A. Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis. J Neurosci Res 2005;81:687–695.
   PubMed Web of Science ®Google Scholar
• Adams S, Green P, Claxton R, Simcox S, Williams MV, Walsh K, Leeuwenburgh C. Reactive carbonyl formation by oxidative and non-oxidative pathways. Front Biosci 2001;6:17–24.
   Web of Science ®Google Scholar
• Bizzozero OA, Ziegler JL, DeJesus G, Bolognani F. Acute depletion of reduced glutathione causes extensive carbonylation of rat brain proteins. J Neurosci Res 2006;83:656–667.
   PubMedGoogle Scholar
• Bizzozero OA, Reyes S, Ziegler JL, Smerjac S. Lipid peroxidation scavengers prevent the carbonylation of cytoskeletal brain proteins induced by glutathione depletion. Neurochem Res 2007;32:2114–2122.
   PubMed Web of Science ®Google Scholar
• Zheng J, Reyes S, Bizzozero OA. Effect of hydralazine and other carbonyl scavengers at preventing the carbonylation of brain proteins induced by GSH depletion. J Neurochem 2008;104(Suppl 1):PTW06–PTW15.
   Google Scholar
• Nourooz-Zadeh A, Tajaddini-Sarmadi J, Ling KL, Wolff SP. Low-density lipoprotein is the major carrier of lipid hydroper-oxides in plasma. Biochem J 1996;313:781–786.
   PubMed Web of Science ®Google Scholar
• Riddles PW, Blakely RL, Zerner B. Ellman's reagent: 5,5’-dithiobis (2-nitrobenzoic acid)—a reexamination. Anal Biochem 1979;94:75–81.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
   PubMed Web of Science ®Google Scholar
• Semsei I, Nagy K, Zs-Nagy I. In vitro studies on the OH and O2-free radical scavenger properties of idebenone in chemical systems. Arch Gerontol Geriatr 1990;11:187–197.
   Google Scholar
• Buchmuller-Rouiller Y, Corrandin SB, Smith J, Schneider P, Ransijn A, Jongeneel CV, Mauel J. Role of glutathione in macrophage activation: effect of cellular glutathione depletion on nitrite production and leishmanicidal activity. Cell Immunol 1995;164:73–80.
   PubMed Web of Science ®Google Scholar
• Kaminskas LM, Pyke SM, Burcham PC. Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice. J Pharmacol Exp Ther 2004;310:1003–1010.
   Google Scholar
• Al-Abed Y, Bucala R. Efficient scavenging of fatty acid oxidation products by aminoguanidine. Chem Res Toxicol 1997;10:875–879.
   PubMed Web of Science ®Google Scholar
• Tang SC, Arumugam TV, Cutler RG, Jo DG, Magnus T, Chan SL, Mughal MR, Telljohann, RS, Nassar M, Ouyang X, Calderan A, Ruzza P, Guiotto A, Mattson MP. Neuroprotective actions of a histidine analogue in models of ischemic stroke. J Neurochem 2007;101:729–736.
   PubMed Web of Science ®Google Scholar
• Burcham PC, Fontaine FR, Kaminskas LM, Petersen DR, Pyke SM. Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity. Mol Pharmacol 2004;65:655–664.
   PubMedGoogle Scholar
• Voziyan PA, Metz TO, Baynes JW, Hudson BG. A post-amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem 2002;277:3397–3403.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Brownson C. A possible new role for the anti-aging peptide carnosine. Cell Mol Life Sci 2000;57:747–753.
   Google Scholar
• Devamanoharan PS, Ali AH, Varma SD. Prevention of lens protein glycation by taurine. J Mol and Cell Biochem 1997;177:245–250.
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end oxidative damage to proteins. Potential diseases and therapeutic prospects inhibitors. Br J Pharmacol 2008;153:6–20.
   PubMed Web of Science ®Google Scholar
• Münzel T, Kurz S, Rajagopalan S, Thoenes M, Berrington WR, Thompson JA, Freeman BA, Harrison DG. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J Clin Invest 1996;98:1465–1470.
   PubMed Web of Science ®Google Scholar
• Maher P, Davis JB. The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 1996;16:6394–6401.
   PubMed Web of Science ®Google Scholar
• 't Hart BA, Simons JM, Knaan-Shanzer S, Bakker NP, Labadie RP. Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin. Free Radic Biol Med 1990;9:127–131.
   PubMedGoogle Scholar
• Roh JH, Suzuki H, Azakami H, Yamashita M, Murooka Y, Kumagai H. Purification, characterization, and crystallization of monoamine oxidase from Escherichia coli. Biosci Biotechnol Biochem 1994;58:1652–1656.
   PubMed Web of Science ®Google Scholar
• Kishi H, Kishi T, Folkers K. Bioenergetics in clinical medicine. III. Inhibition of conezyme Q10-enzymes by clinically used antihypertensive agents. Res Commun Chem Pathol Pharmacol 1975;12:533–540.
   Google Scholar
• Daiber A, Oelze M, Coldewey M, Kaiser K, Huth C, Schildknecht S, Bachschmid M, Nazirisadeh Y, Ullrich V, Mülsch A, Münzel T, Tsilimingas N. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. Biochem Biophys Res Commun 2005;338:1865–1874.
   PubMed Web of Science ®Google Scholar
• Refsgaard HF, Tsai L, Stadman ER. Modification of proteins by polyunsaturated fatty acid peroxidation products. Proc Natl Acad Sci USA 2000;97:611–691.
   PubMed Web of Science ®Google Scholar
• Pennathur S, Ido Y, Heller JI, Byun J, Danda R, Pergola P, Williamson JR, Heinecke JW. Reactive carbonyls and polyun-saturated fatty acids produce hydroxyl radical-like species. J Biol Chem 2005;280:22706–22714.
   PubMed Web of Science ®Google Scholar
• Bizzozero OA. . Protein carbonylation in neurodegenerative and demyelinating CNS diseasesLajtha, Banik, Ray, Handbook of neurochemistry and molecular neurobiology—Brain and spinal cord trauma. Springer; 2008. Chapter 23.543–562.
   Google Scholar
• Smerjac S, Bizzozero OA. Cytoskeletal protein carbonylation and degradation in experimental autoimmune encephalomyelitis. J Neurochem 2008;105:763–772.
   Google Scholar
• Requena JS, Chao CC, Levine R, Stadtman ER. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci USA 2001;98:69–74.
   PubMed Web of Science ®Google Scholar
• Pamplona R, Dalfo E, Ayala V, Bellmunt MJ, Prat J, Ferrer I, Portero-Otin M. Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. J Biol Chem 2005;280:21522–21530.
   PubMed Web of Science ®Google Scholar
• Metha R, Wong L, O’Brien PJ. Cytoprotective mechanisms of carbonyl scavenging drugs in isolated rat hepatocytes. Chem-Biol Interact 2009;178:317–323.
   Google Scholar
• Leiro JM, Alvarez E, Arranz JA, Cano E, Orallo F. Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in peritoneal macrophages. Int Immunopharmacol 2004;4:163–177.
   PubMed Web of Science ®Google Scholar
• Svensson CK, Knowlton PW, Ware JA. Effect of hydralazine on the elimination of antipyrine in the rat. Pharm Res 1987;4:515–518.
   PubMed Web of Science ®Google Scholar